Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice

Virology

Volumn 497, Issue , 2016, Pages 102-110

  Liu, Rui ^a   Wang, Jingbo ^a   Yang, Yan ^a   Khan, Inamullah ^a   Zhu, Naishuo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adjuvant; Imiquimod; Lipopeptide; Rabies vaccine; TLR7

Indexed keywords

ADJUVANT; CE 536; GAMMA INTERFERON; I KAPPA B ALPHA; IMIQUIMOD; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; INTERFERON; LIPOPEPTIDE; NEUTRALIZING ANTIBODY; RABIES VACCINE; RABIES VIRUS LIPOPEPTIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG CONJUGATION; DRUG STRUCTURE; FEMALE; HUMORAL IMMUNITY; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TH1 CELL; AGONISTS; ANIMAL; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MORTALITY; RABIES; RABIES VIRUS; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, VIRAL; CYTOKINES; DENDRITIC CELLS; FEMALE; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOCONJUGATES; LIPOPEPTIDES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RABIES; RABIES VACCINES; RABIES VIRUS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TOLL-LIKE RECEPTOR 7;

EID: 84978768112     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.06.019     Document Type: Article

References (39)

1. Baccarella, A., Fontana, M.F., Chen, E.C., Kim, C.C., Toll-like receptor 7 mediates early innate immune responses to malaria. Infect. Immun. 81 (2013), 4431–4442.
2. Barkhouse, D.A., Garcia, S.A., Bongiorno, E.K., Lebrun, A., Faber, M., Hooper, D.C., Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. J. Virol. 89 (2015), 312–322.
3. Brzozka, K., Finke, S., Conzelmann, K.K., Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79 (2005), 7673–7681.
4. Carty, M., Reinert, L., Paludan, S.R., Bowie, A.G., Innate antiviral signalling in the central nervous system. Trends Immunol. 35 (2014), 79–87.
5. Chan, M., Hayashi, T., Kuy, C.S., Gray, C.S., Wu, C.C.N., Corr, M., Wrasidlo, W., Cottam, H.B., Carson, D.A., Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates. Bioconjug. Chem. 20 (2009), 1194–1200.
6. Crespo, M.I., Zacca, E.R., Nunez, N.G., Ranocchia, R.P., Maccioni, M., Maletto, B.A., Pistoresi-Palencia, M.C., Moron, G., TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8alpha+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface. J. Immunol. 190 (2013), 948–960.
7. Cruz, L.J., Rueda, F., Simon, L., Cordobilla, B., Albericio, F., Domingo, J.C., Liposomes containing NYESO1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines. Nanomedicine 9 (2014), 435–449.
8. Dunne, A., O'Neill, L.A., The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE, 2003, re3.
9. Faul, E.J., Wanjalla, C.N., Suthar, M.S., Gale, M., Wirblich, C., Schnell, M.J., Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog., 6, 2010, e1001016.
10. Gomme, E.A., Faul, E.J., Flomenberg, P., McGettigan, J.P., Schnell, M.J., Characterization of a single-cycle rabies virus-based vaccine vector. J. Virol. 84 (2010), 2820–2831.
11. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002), 621–667.
12. Haas, F., Yamauchi, K., Murat, M., Bernasconi, M., Yamanaka, N., Speck, R.F., Nadal, D., Activation of NF-kappaB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation. J. Virol. 88 (2014), 10002–10012.
13. Hampson, K., Coudeville, L., Lembo, T., Sambo, M., Kieffer, A., Attlan, M., Barrat, J., Blanton, J.D., Briggs, D.J., Cleaveland, S., Costa, P., Freuling, C.M., Hiby, E., Knopf, L., Leanes, F., Meslin, F.X., Metlin, A., Miranda, M.E., Muller, T., Nel, L.H., Recuenco, S., Rupprecht, C.E., Schumacher, C., Taylor, L., Vigilato, M.A., Zinsstag, J., Dushoff, J., Global Alliance for Rabies Control Partners for Rabies Prevention, Estimating the global burden of endemic canine rabies. PLoS Negl. Trop. Dis., 9, 2015, e0003709.
14. Heer, A.K., Shamshiev, A., Donda, A., Uematsu, S., Akira, S., Kopf, M., Marsland, B.J., TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178 (2007), 2182–2191.
15. Hoshino, K., Sasaki, I., Sugiyama, T., Yano, T., Yamazaki, C., Yasui, T., Kikutani, H., Kaisho, T., Critical role of IkappaB Kinase alpha in TLR7/9-induced type I IFN production by conventional dendritic cells. J. Immunol. 184 (2010), 3341–3345.
16. Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H.J., Kopf, M., Bachmann, M.F., TLR9 signaling in B cells determines class switch recombination to IgG2a. J. Immunol. 178 (2007), 2415–2420.
17. Jeisy-Scott, V., Kim, J.H., Davis, W.G., Cao, W., Katz, J.M., Sambhara, S., TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. J. Virol. 86 (2012), 10988–10998.
18. Jeisy-Scott, V., Davis, W.G., Patel, J.R., Bowzard, J.B., Shieh, W.J., Zaki, S.R., Katz, J.M., Sambhara, S., Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS One, 6, 2011, e25242.
19. Johnson, N., Cunningham, A.F., Fooks, A.R., The immune response to rabies virus infection and vaccination. Vaccine 28 (2010), 3896–3901.
20. Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S., Medzhitov, R., TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9 (2008), 361–368.
21. Kasturi, S.P., Skountzou, I., Albrecht, R.A., Koutsonanos, D., Hua, T., Nakaya, H.I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., Villinger, F., Murthy, N., Steel, J., Jacob, J., Hogan, R.J., Garcia-Sastre, A., Compans, R., Pulendran, B., Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470 (2011), 543–547.
22. Kaur, G., Charu, Charu, Bansal, A., rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium. Cell. Mol. Immunol. 12 (2015), 96–106.
23. Kawasaki, T., Kawai, T., Toll-like receptor signaling pathways. Front. Immunol., 5, 2014, 461.
24. Khairuddin, N., Gantier, M.P., Blake, S.J., Wu, S.Y., Behlke, M.A., Williams, B.R., McMillan, N.A., siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo. Immunol. Cell Biol. 90 (2012), 187–196.
25. Koyama, S., Aoshi, T., Tanimoto, T., Kumagai, Y., Kobiyama, K., Tougan, T., Sakurai, K., Coban, C., Horii, T., Akira, S., Ishii, K.J., Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci. Transl. Med., 2, 2010, 25ra24.
26. Larange, A., Antonios, D., Pallardy, M., Kerdine-Romer, S., TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J. Leukoc. Biol. 85 (2009), 673–683.
27. Lester, S.N., Li, K., Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426 (2014), 1246–1264.
28. Li, J., Faber, M., Dietzschold, B., Hooper, D.C., The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv. Virus Res. 79 (2011), 115–126.
29. Liu, R., Wang, J., Yang, Y., Khan, I., Dong, Y., Zhu, N., A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses. Virus Res. 221 (2016), 66–73.
30. O'Neill, L.A., Golenbock, D., Bowie, A.G., The history of Toll-like receptors – redefining innate immunity. Nat. Rev. Immunol. 13 (2013), 453–460.
31. Shinchi, H., Crain, B., Yao, S., Chan, M., Zhang, S.S., Ahmadiiveli, A., Suda, Y., Hayashi, T., Cottam, H.B., Carson, D.A., Enhancement of the immunostimulatory activity of a TLR7 ligand by conjugation to polysaccharides. Bioconjug.Chem. 26 (2015), 1713–1723.
32. Song, Y.C., Liu, S.J., A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms. Sci. Rep., 5, 2015, 12578.
33. Taylor, J.J., Pape, K.A., Steach, H.R., Jenkins, M.K., Humoral immunity. Apoptosis and antigen affinity limit effector cell differentiation of a single naive B cell. Science 347 (2015), 784–787.
34. Tjiam, M.C., Taylor, J.P., Morshidi, M.A., Sariputra, L., Burrows, S., Martin, J.N., Deeks, S.G., Tan, D.B., Lee, S., Fernandez, S., French, M.A., Viremic HIV controllers exhibit high plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibody responses against HIV-1 p24 associated with greater antibody isotype diversification. J. Immunol. 194 (2015), 5320–5328.
35. Wang, C., Zhou, Q., Wang, X., Wu, X., Chen, X., Li, J., Zhu, Z., Liu, B., Su, L., The TLR7 agonist induces tumor regression both by promoting CD4(+)T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells. Oncotarget 6 (2015), 1779–1789.
36. Wang, X., Bao, M., Wan, M., Wei, H., Wang, L., Yu, H., Zhang, X., Yu, Y., Wang, L., A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine. Vaccine 26 (2008), 1893–1901.
37. Wille-Reece, U., Wu, C.Y., Flynn, B.J., Kedl, R.M., Seder, R.A., Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. J. Immunol. 174 (2005), 7676–7683.
38. Yendo, A.C., de Costa, F., Cibulski, S.P., Teixeira, T.F., Colling, L.C., Mastrogiovanni, M., Soule, S., Roehe, P.M., Gosmann, G., Ferreira, F.A., Fett-Neto, A.G., A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge. Vaccine 34 (2016), 2305–2311.
39. Zhang, A.J., Li, C., Zhu, K.K., Lee, H.S., Li, A.C., Chan, C.G., Hung, J.F., Yuen, K.Y, I.F., Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice. Clin. Vaccine Immunol. 21 (2014), 570–579.